PDT dose dosimetry for Photofrin-mediated pleural photodynamic therapy (pPDT)

• Published in: Physics in medicine & biology 2017-12, Vol.63 (1), p.015031-015031
• Main Authors: Ong, Yi Hong, Kim, Michele M, Finlay, Jarod C, Dimofte, Andreea, Singhal, Sunil, Glatstein, Eli, Cengel, Keith A, Zhu, Timothy C
• Format: Article
• Language: English
• Subjects: Clinical Trials, Phase II as Topic; Dihematoporphyrin Ether - therapeutic use; Fluorescence; Humans; Mesothelioma - drug therapy; Mesothelioma - metabolism; Mesothelioma - pathology; Monte Carlo Method; Monte Carlo simulation; optical properties correction; PDT dose; Phantoms, Imaging; Photochemotherapy; photodynamic therapy; Photofrin; Photosensitizing Agents - therapeutic use; Pleural Neoplasms - drug therapy; Pleural Neoplasms - metabolism; Pleural Neoplasms - pathology; Radiometry - methods; Randomized Controlled Trials as Topic; Spectrometry, Fluorescence
• ISSN: 0031-9155; 1361-6560; 1361-6560
• DOI: 10.1088/1361-6560/aa9874

Photosensitizer fluorescence excited by photodynamic therapy (PDT) treatment light can be used to monitor the in vivo concentration of the photosensitizer and its photobleaching. The temporal integral of the product of in vivo photosensitizer concentration and light fluence is called PDT dose, which is an important dosimetry quantity for PDT. However, the detected photosensitizer fluorescence may be distorted by variations in the absorption and scattering of both excitation and fluorescence light in tissue. Therefore, correction of the measured fluorescence for distortion due to variable optical properties is required for absolute quantification of photosensitizer concentration. In this study, we have developed a four-channel PDT dose dosimetry system to simultaneously acquire light dosimetry and photosensitizer fluorescence data. We measured PDT dose at four sites in the pleural cavity during pleural PDT. We have determined an empirical optical property correction function using Monte Carlo simulations of fluorescence for a range of physiologically relevant tissue optical properties. Parameters of the optical property correction function for Photofrin fluorescence were determined experimentally using tissue-simulating phantoms. In vivo measurements of photosensitizer fluorescence showed negligible photobleaching of Photofrin during the PDT treatment, but large intra- and inter-patient heterogeneities of in vivo Photofrin concentration are observed. PDT doses delivered to 22 sites in the pleural cavity of 8 patients were different by 2.9 times intra-patient and 8.3 times inter-patient.